Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

Autor: Jiao Zhang, Zhen Chen, Youyi Zhang, Ting Lei, Han Xiao, Fenqing Shang, Traci L. Marin, Brendan Gongol, Zhao Li, Jin Zhang, Yanjun Yin, John Y.-J. Shyy, Yaqiong Wang
Přispěvatelé: Huang, Yu
Rok vydání: 2016
Předmět:
Male
Poly (ADP-Ribose) Polymerase-1
Blood Pressure
AMP-Activated Protein Kinases
Cardiovascular
Biochemistry
Vascular Medicine
Mice
0302 clinical medicine
Endocrinology
AMP-activated protein kinase
Rats
Inbred SHR

lcsh:Science
Cells
Cultured

Cultured
Organic Compounds
Metformin
3. Good health
5.1 Pharmaceuticals
Physical Sciences
Phosphorylation
Poly(ADP-ribose) Polymerases
Development of treatments and therapeutic interventions
Western
Metoprolol
medicine.medical_specialty
Inbred SHR
Cardiotonic Agents
Endothelium
Endocrine Disorders
MAP Kinase Signaling System
Cells
Knockout
Blotting
Western

Carbohydrates
Nitric Oxide
03 medical and health sciences
Diabetes Mellitus
Humans
Protein kinase A
Pharmacology
lcsh:R
Chemical Compounds
Biology and Life Sciences
Proteins
medicine.disease
Mice
Inbred C57BL

030104 developmental biology
Glucose
Hyperglycemia
Blood Vessels
lcsh:Q
Benzimidazoles
Endothelium
Vascular

0301 basic medicine
lcsh:Medicine
030204 cardiovascular system & hematology
Inbred C57BL
Rats
Inbred WKY

Benzoates
Medicine and Health Sciences
Telmisartan
Endothelial dysfunction
Post-Translational Modification
Aorta
Mice
Knockout

Multidisciplinary
biology
Blotting
Monosaccharides
Diabetes
Drugs
Chemistry
medicine.anatomical_structure
Antihypertensive Drugs
Hypertension
Anatomy
medicine.drug
Research Article
General Science & Technology
Real-Time Polymerase Chain Reaction
Internal medicine
Vascular
medicine
Animals
Inbred WKY
Organic Chemistry
AMPK
Cell Biology
Rats
Oxidative Stress
Metabolic Disorders
biology.protein
Cardiovascular Anatomy
Glipizide
Zdroj: PloS one, vol 11, iss 3
PLoS ONE
PLoS ONE, Vol 11, Iss 3, p e0151845 (2016)
Popis: Hyperglycemia and hypertension impair endothelial function in part through oxidative stress-activated poly (ADP-ribose) polymerase 1 (PARP1). Biguanides and angiotensin II receptor blockers (ARBs) such as metformin and telmisartan have a vascular protective effect. We used cultured vascular endothelial cells (ECs), diabetic and hypertensive rodent models, and AMPKα2-knockout mice to investigate whether metformin and telmisartan have a beneficial effect on the endothelium via AMP-activated protein kinase (AMPK) phosphorylation of PARP1 and thus inhibition of PARP1 activity. The results showed that metformin and telmisartan, but not glipizide and metoprolol, activated AMPK, which phosphorylated PARP1 Ser-177 in cultured ECs and the vascular wall of rodent models. Experiments using phosphorylated/de-phosphorylated PARP1 mutants show that AMPK phosphorylation of PARP1 leads to decreased PARP1 activity and attenuated protein poly(ADP-ribosyl)ation (PARylation), but increased endothelial nitric oxide synthase (eNOS) activity and silent mating type information regulation 2 homolog 1 (SIRT1) expression. Taken together, the data presented here suggest biguanides and ARBs have a beneficial effect on the vasculature by the cascade of AMPK phosphorylation of PARP1 to inhibit PARP1 activity and protein PARylation in ECs, thereby mitigating endothelial dysfunction.
Databáze: OpenAIRE